MedPath

Painless Myocardial Ischemia in Diabetic Patients.

Completed
Conditions
Painless Myocardial Ischemia
Interventions
Diagnostic Test: ELISA Test
Registration Number
NCT04071808
Lead Sponsor
Second Hospital of Shanxi Medical University
Brief Summary

This study aims to investigate the relationship between the concentrations of blood orphanin, norepinephrine and the morbidity of painless myocardial ischemia in patients with diabetes mellitus. Hopefully, the biomarker(s) in the blood of diabetic patients can be found for screening high risk patients in the diabetes sufferers to prevent the painless myocardial ischemia.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
120
Inclusion Criteria
  • Subject has diabetes
Exclusion Criteria
  • History of myocardial ischemia
  • Symptoms of myocardial ischemia(ECG changes except)

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Coronary angiography groupELISA TestIn diabetic patients without symptoms of myocardial ischemia, coronary angiography showed no stenosis or stenosis less than 75%.
Coronary angiographic stent implantation groupELISA TestCoronary angiographic stenosis was more than 75% in diabetic patients without myocardial ischemia symptoms, and coronary stents were implanted.
Primary Outcome Measures
NameTimeMethod
Blood orphanin content24 hours

Blood orphanin levels in painless diabetic patients with myocardial ischemia requiring interventional therapy and diabetic patients without interventional therapy.

Blood norepinephrine content24 hours

Blood norepinephrine levels in diabetic patients with painless myocardial ischemia requiring interventional therapy and diabetic patients without interventional therapy

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Second of Shanxi Medical University

🇨🇳

Taiyuan, Shanxi, China

© Copyright 2025. All Rights Reserved by MedPath